14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $8.74 $12.25 Wednesday, 1st May 2024 PHAT stock ended at $9.26. This is 2.55% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.36% from a day low at $8.96 to a day high of $9.53.
90 days $6.07 $12.25
52 weeks $6.07 $17.00

Historical Phathom Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
Jun 08, 2023 $11.75 $12.32 $11.70 $12.30 189 035
Jun 07, 2023 $11.68 $11.90 $11.52 $11.75 282 906
Jun 06, 2023 $11.71 $11.81 $11.53 $11.64 203 901
Jun 05, 2023 $11.57 $11.82 $11.48 $11.70 193 411
Jun 02, 2023 $11.41 $11.83 $11.41 $11.66 185 416
Jun 01, 2023 $11.76 $11.91 $11.40 $11.63 263 880
May 31, 2023 $11.50 $12.05 $11.34 $11.76 492 496
May 30, 2023 $11.76 $12.11 $11.37 $11.40 328 420
May 26, 2023 $11.69 $11.98 $11.57 $11.76 425 595
May 25, 2023 $11.81 $11.85 $11.40 $11.72 432 463
May 24, 2023 $11.85 $12.13 $11.41 $11.71 2 991 199
May 23, 2023 $13.44 $13.80 $12.96 $13.07 205 942
May 22, 2023 $12.88 $13.62 $12.87 $13.48 181 372
May 19, 2023 $13.10 $13.35 $12.92 $13.24 113 855
May 18, 2023 $13.24 $13.43 $12.54 $12.94 120 107
May 17, 2023 $12.55 $13.42 $12.27 $13.27 174 232
May 16, 2023 $12.29 $12.70 $12.05 $12.51 159 501
May 15, 2023 $13.57 $13.69 $12.48 $12.59 325 758
May 12, 2023 $13.25 $14.23 $13.20 $13.46 349 422
May 11, 2023 $13.46 $14.42 $12.95 $13.19 556 321
May 10, 2023 $12.21 $12.74 $11.24 $12.43 363 586
May 09, 2023 $12.43 $12.50 $11.80 $11.99 249 459
May 08, 2023 $12.42 $13.28 $12.10 $12.34 520 594
May 05, 2023 $11.84 $12.56 $11.71 $12.35 600 524
May 04, 2023 $11.64 $12.00 $11.31 $11.70 360 087
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT